Q-Centrix and Realyze Intelligence Partner to Advance the Automation of High-Quality Clinical Data and Drive Better Patient Care
January 06, 2022 09:00 ET
|
Q-Centrix
CHICAGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Q-Centrix®, the largest exclusive provider of clinical data management solutions to hospitals and health systems, today announced a partnership with...
Global Electronic Health Record (EHR) Markets, 2021-2026 - Rapid Increase in Digitalization and Growing Competition to Positively Impact the Market
January 06, 2022 04:38 ET
|
Research and Markets
Dublin, Jan. 06, 2022 (GLOBE NEWSWIRE) -- The "Electronic Health Record Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global electronic...
Sema4 to Participate at the 40th Annual J.P. Morgan Healthcare Conference in January
January 03, 2022 16:05 ET
|
Sema4
STAMFORD, Conn., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that Eric Schadt, PhD, Founder and...
Q-Centrix Launches First-of-its-Kind, Comprehensive Oncology Solution Within its' Enterprise Clinical Data Management (eCDM™) Platform
December 09, 2021 09:00 ET
|
Q-Centrix
CHICAGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Q-Centrix®, the largest exclusive provider of clinical data management solutions to hospitals and health systems, today announced the launch of the first...
Immunicum tillkännager avslutad Fas Ib och tidig stängning av ILIAD-studien
December 03, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande 3 december 2021 Immunicum tillkännager avslutad Fas Ib och tidig stängning av ILIAD-studienImmunicum AB (“Immunicum”, publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på...
Immunicum Announces Completion of Phase Ib Portion and Early Closure of ILIAD Study
December 03, 2021 02:00 ET
|
Immunicum AB
Press Release Stockholm, Sweden, December 3, 2021 Immunicum Announces Completion of Phase Ib Portion and Early Closure of ILIAD Study Immunicum AB (“Immunicum”, publ; IMMU.ST), a biopharmaceutical...
Imara Announces Interim Analysis Data from Forte Phase 2b Clinical Trial of Tovinontrine (IMR-687) in Transfusion-Dependent Subjects with Beta-thalassemia
November 16, 2021 07:00 ET
|
Imara, Inc.
Positive trend observed in transfusion-dependent subjects treated with higher dose tovinontrine for reduced transfusion burden Tovinontrine was generally well-tolerated in this patient population ...
Sema4 Reports Third Quarter 2021 Financial Results and Business Highlights
November 15, 2021 16:01 ET
|
Sema4
36% increase in test volume (excluding COVID-19 tests) compared to the same period last year 17% growth in revenue (excluding COVID-19 tests) compared to the same period last year ...
Sema4 and Mount Sinai use Machine Learning to Improve Postpartum Hemorrhage Risk Prediction
November 04, 2021 08:00 ET
|
Sema4
STAMFORD, Conn., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ: SMFR), an AI-driven genomic and clinical data intelligence platform company, recently published two studies demonstrating the...
Q-Centrix Launches Institute to Solve Unabating Demand for High-Quality, Curated Clinical Data
October 20, 2021 09:00 ET
|
Q-Centrix
CHICAGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Q-Centrix®, the largest exclusive provider of clinical data management solutions to hospitals and health systems, today announced the rollout of their...